chr3-132447336-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 3P and 2B. PM2PP2BP4_Moderate
The NM_015268.4(DNAJC13):āc.160A>Gā(p.Ile54Val) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000007 in 1,427,876 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_015268.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAJC13 | NM_015268.4 | c.160A>G | p.Ile54Val | missense_variant | 4/56 | ENST00000260818.11 | NP_056083.3 | |
DNAJC13 | NM_001329126.2 | c.160A>G | p.Ile54Val | missense_variant | 4/57 | NP_001316055.1 | ||
DNAJC13 | XM_047447819.1 | c.160A>G | p.Ile54Val | missense_variant | 4/57 | XP_047303775.1 | ||
DNAJC13 | XM_047447820.1 | c.160A>G | p.Ile54Val | missense_variant | 4/56 | XP_047303776.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAJC13 | ENST00000260818.11 | c.160A>G | p.Ile54Val | missense_variant | 4/56 | 1 | NM_015268.4 | ENSP00000260818.6 | ||
DNAJC13 | ENST00000486798.5 | n.225A>G | non_coding_transcript_exon_variant | 4/20 | 1 | |||||
DNAJC13 | ENST00000650455.1 | n.160A>G | non_coding_transcript_exon_variant | 4/57 | ENSP00000496825.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 7.00e-7 AC: 1AN: 1427876Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 710292
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 06, 2023 | The c.160A>G (p.I54V) alteration is located in exon 4 (coding exon 3) of the DNAJC13 gene. This alteration results from a A to G substitution at nucleotide position 160, causing the isoleucine (I) at amino acid position 54 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at